vimarsana.com

Page 27 - வரைவு சிவப்பு ஹெர்ரிங் ப்ரோஸ்பெக்டஸ் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

COVID-19 vaccine woes, adequate oxygen supply, and ABSL AMC IPO: Three things investors should know on April 20, 2021

: Tuesday, April 20, 2021, 5:33 PM IST COVID-19 vaccine woes, adequate oxygen supply, and ABSL AMC IPO: Three things investors should know on April 20, 2021 India s Vaccine Woes The vaccine production in India has taken a severe hit in the absence of key ingredients. The issue has magnified ever since the United States has imposed restrictions on the export of key ingredients. The United States has invoked the war-time Defence Production Act (DPA). It forces US-based companies to prioritize the supply of raw materials to domestic companies only. The US has so far expressed concerns over India s plight. But little has materialized on the ground.

Glenmark Life Sciences IPO: Glenmark Life Sciences files papers for IPO with Sebi

Explore Now NEW DELHI: Glenmark Pharmaceuticals on Saturday said its wholly-owned arm Glenmark Life Sciences has filed preliminary papers for an initial public offer with market regulator Sebi. The offer comprises fresh issue of up to Rs 1,160 crore and an offer for sale of up to 73,05,245 equity shares of Rs 2 each of Glenmark Life Sciences Ltd, by The board of directors of Glenmark Pharmaceuticals Ltd during its meeting on April 16 approved the offer for sale of up to 73,05,245 equity shares of Rs 2 apiece as part of the IPO. The IPO will be subject to market conditions, receipt of applicable approvals and other considerations, the filing said.

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.